TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma

Peer Review reports

Original Submission
23 Dec 2021	Submitted	Original manuscript
8 Apr 2022	Reviewed	Reviewer Report
14 May 2022	Reviewed	Reviewer Report
2 Jun 2022	Author responded	Author comments - Elodie COQUAN
Resubmission - Version 2
2 Jun 2022	Submitted	Manuscript version 2
25 Jun 2022	Reviewed	Reviewer Report
26 Jun 2022	Reviewed	Reviewer Report
10 Sep 2022	Reviewed	Reviewer Report - Rafael Morales-Barrera
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
22 Oct 2022	Editorially accepted
24 Nov 2022	Article published	10.1186/s12885-022-10216-z

Back to article page